TY  - GEN
AU  - Saber,Sameh
AU  - Mahmoud,Amr A A
AU  - Goda,Reham
AU  - Helal,Noha S
AU  - El-Ahwany,Eman
AU  - Abdelghany,Rasha H
TI  - Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B
SN  - 1879-3169
PY  - 2018///0827
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - pharmacology
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Animals
KW  - Antineoplastic Agents
KW  - Carcinoma, Hepatocellular
KW  - chemically induced
KW  - Cyclin D1
KW  - genetics
KW  - Diethylnitrosamine
KW  - Fosinopril
KW  - Liver Neoplasms, Experimental
KW  - Losartan
KW  - Male
KW  - Matrix Metalloproteinase 2
KW  - metabolism
KW  - Mice
KW  - NF-KappaB Inhibitor alpha
KW  - NF-kappa B
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Perindopril
KW  - Phenylurea Compounds
KW  - Phosphorylation
KW  - Renin-Angiotensin System
KW  - drug effects
KW  - Signal Transduction
KW  - Sorafenib
KW  - Time Factors
KW  - Transcription Factor RelA
KW  - Transforming Growth Factor beta1
KW  - Tumor Necrosis Factor-alpha
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1016/j.toxlet.2018.05.036
ER  -